Stay updated on PATHWay Study: Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page adds a recruitment status notice indicating no further participant enrollment and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also changes the heading formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and removes the 'Revision: v3.5.5' text, reflecting an updated site version.SummaryDifference0.4%

- Check20 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5. This indicates a new administrative refresh of the study record.SummaryDifference0.1%

- Check42 days agoChange DetectedThe study record now indicates that results have been posted and includes updated completion dates and related study documents, reflecting the PATHWay trial's final data availability. This update communicates the trial's progression to results reporting and final status to users reviewing the record.SummaryDifference3%

- Check63 days agoChange DetectedThe page revision/version has been incremented from v3.5.2 to v3.5.3, indicating a backend or release update without altering the displayed study information.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.1%

- Check99 days agoChange DetectedSite revision updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to PATHWay Study: Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.